DEFINITIVE NOTICE AND PROXY STATEMENT

Company

Ernexa Therapeutics Inc.

Filed

April 30, 2010

Period of Report

June 2, 2010

Accession Number

0001019687-10-001606

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →